811 related articles for article (PubMed ID: 29372812)
21. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
[TBL] [Abstract][Full Text] [Related]
22. Pseudomonas aeruginosa: evolution of antimicrobial resistance and implications for therapy.
McCarthy K
Semin Respir Crit Care Med; 2015 Feb; 36(1):44-55. PubMed ID: 25643270
[TBL] [Abstract][Full Text] [Related]
23.
Faure E; Kwong K; Nguyen D
Front Immunol; 2018; 9():2416. PubMed ID: 30405616
[TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia?
Freestone PP; Hirst RA; Sandrini SM; Sharaff F; Fry H; Hyman S; O'Callaghan C
Chest; 2012 Nov; 142(5):1200-1210. PubMed ID: 22556319
[TBL] [Abstract][Full Text] [Related]
25. Novel therapies for Pseudomonas aeruginosa pneumonia.
Roux D; Ricard JD
Infect Disord Drug Targets; 2011 Aug; 11(4):389-94. PubMed ID: 21679142
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.
Hengzhuang W; Høiby N; Ciofu O
Methods Mol Biol; 2014; 1147():239-54. PubMed ID: 24664838
[TBL] [Abstract][Full Text] [Related]
27. [Foreign body infections--biofilms and quorum sensing].
Høiby N; Johansen HK; Ciofu O; Jensen PØ; Bjarnsholt T; Givskov M
Ugeskr Laeger; 2007 Nov; 169(48):4163-6. PubMed ID: 18211783
[TBL] [Abstract][Full Text] [Related]
28. [Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
Nagata T; Mukae H; Kadokawa T; Kaida H; Kuroki M; Yanagihara K; Asano K; Kadota J; Koji T; Kawano S
Jpn J Antibiot; 2003 Apr; 56 Suppl A():57-9. PubMed ID: 14679749
[No Abstract] [Full Text] [Related]
29. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
31. Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies.
Høiby N
J Cyst Fibros; 2002 Dec; 1(4):249-54. PubMed ID: 15463822
[TBL] [Abstract][Full Text] [Related]
32. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
Chen C; Deslouches B; Montelaro RC; Di YP
Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
[TBL] [Abstract][Full Text] [Related]
33. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
Field TR; White A; Elborn JS; Tunney MM
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
[TBL] [Abstract][Full Text] [Related]
34. Microbial Biofilms in Pulmonary and Critical Care Diseases.
Boisvert AA; Cheng MP; Sheppard DC; Nguyen D
Ann Am Thorac Soc; 2016 Sep; 13(9):1615-23. PubMed ID: 27348071
[TBL] [Abstract][Full Text] [Related]
35. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients.
Sans-Serramitjana E; Fusté E; Martínez-Garriga B; Merlos A; Pastor M; Pedraz JL; Esquisabel A; Bachiller D; Vinuesa T; Viñas M
J Cyst Fibros; 2016 Sep; 15(5):611-8. PubMed ID: 26708265
[TBL] [Abstract][Full Text] [Related]
36. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
Dosler S; Karaaslan E
Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
[TBL] [Abstract][Full Text] [Related]
37. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
[TBL] [Abstract][Full Text] [Related]
38. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
[TBL] [Abstract][Full Text] [Related]
39. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
[TBL] [Abstract][Full Text] [Related]
40. Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms.
Beaudoin T; Stone TA; Glibowicka M; Adams C; Yau Y; Ahmadi S; Bear CE; Grasemann H; Waters V; Deber CM
Sci Rep; 2018 Oct; 8(1):14728. PubMed ID: 30283025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]